Latest News & Features
Americas
The IP team at AstraZeneca must “ruthlessly” prioritise how it spends time and resources, its vice president of global IP explained in an interview. 8 March 2018
Europe
The European Patent Office has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology. 7 March 2018
Americas
AstraZeneca’s research development arm MedImmune has revealed plans to spin out six molecules into an independent biotech company. 6 March 2018
Americas
Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox. 6 March 2018
Americas
The financial stakes in the biosimilars market are enormous, and an understanding of sequence IP for the underlying technologies and modes of action is key to entry into it, say Henk Heus and Ellen Sherin of GQ Life Sciences. 6 March 2018
Big Pharma
The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit. 5 March 2018
Americas
Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court. 5 March 2018
Americas
The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity. 2 March 2018
Europe
The EU General Court has dismissed a request to revoke a syringe trademark on the grounds of non-use, partially affirming the initial decision of the Cancellation Division. 1 March 2018
Americas
DowDuPont, a specialist in agriculture, materials science and speciality products, has revealed the names of three independent companies that it intends on creating. 1 March 2018